glp-1 agonists and retained gastric contents at endoscopy Receptor Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus GLP-1 Receptor Agonists in Gastrointestinal

Then, we will discuss the approaches that can increase the endogenous production of GLP-1 through various stimuli

The approval could expand access to an effective therapy for managing obesity.

Participation in this program does not replace healthy lifestyle habits, including balanced nutrition and regular movement

This move comes as these diabetes and weight-loss drugs see explosive demand in India, fueled by rising obesity rates and recent price reductions

Learn what to expect from compounded GLP-1/GIP injections here.

A comprehensive phase 3 program is ongoing to evaluate efficacy, safety, and cardiovascular/renal outcomes in people with obesity and/or T2D